Infectious Diseases News and Research

RSS

New TB blood test could eliminate unnecessary treatment

A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives.

6 Jun 2014

Device used in physics and chemistry reveals dynamics of pervasive pathogen

If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of-big, both proportionately and epidemiologically.

6 Jun 2014

Canadian invasive pneumococcal disease outbreak characterised

Canadian scientists have reported details of an outbreak of serotype 12F invasive pneumococcal disease that occurred in Winnipeg between 2009 and 2011 and predominantly affected people who were homeless and/or engaged in illegal drug use.

5 Jun 2014

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.

5 Jun 2014

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers.

5 Jun 2014

NeuroVive extends collaboration with Hospices Civils de Lyon

NeuroVive is extending its collaboration with Hospices Civils de Lyon (HCL) and Professor Ovize, which broadens the scope of NeuroVive's cardiovascular business area and creates the right conditions for the company to retain its leading position in mitochondrial medicine.

4 Jun 2014

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Janssen-Cilag International NV announced today that the European Commission has approved an extension of the oral atypical antipsychotic INVEGA® (paliperidone ER) schizophrenia indication, to include adolescents aged 15 years and older.

4 Jun 2014

Researchers figure out way to disable a part of SARS virus

A Purdue University-led research team has figured out how to disable a part of the SARS virus responsible for hiding it from the immune system; a critical step in developing a vaccine against the deadly disease.

4 Jun 2014

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Polyarticular Juvenile Idiopathic Arthritis (PJIA) is a type of Juvenile Idiopathic Arthritis (JIA), a group of Rheumatoid Arthritis (RA) diseases that manifests in multiple ways in children.

3 Jun 2014

Salk Institute receives $25 million for cutting-edge biological research

The Salk Institute for Biological Studies has received a $25 million gift from San Diego philanthropist and former Salk trustee Conrad T. Prebys to support cutting-edge biological research on a wide range of diseases.

3 Jun 2014

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

We already understand the many steps involved in blood clotting in great mechanistic detail. The process of blood vessels closing off in response to injury is necessary for preserving life, but blood platelets that are over-active, or activated inappropriately because of unstable plaque, can lead to heart attacks and strokes.

3 Jun 2014

UTHealth’s professor receives highly competitive Fulbright-Nehru Scholarship Award

Anil Kulkarni, MSc, Ph.D., professor in the Department of Surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, was awarded a highly competitive Fulbright-Nehru Scholarship Award for Academic and Professional Experience to travel to India this fall to teach immunonutrition and functional foods in the global health era.

31 May 2014

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Sangamo BioSciences, Inc. announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for HIV/AIDS based on the application of Sangamo's zinc finger nuclease (ZFN) genome-editing technology in hematopoietic stem/progenitor cells (HSPCs).

31 May 2014

Viewpoints: VA's problems begin with Congress; costly hepatitis drug may be a good buy

Politically, this critique of the VA is a no-brainer. After all, denying, delaying or incompetently delivering benefits to veterans who are entitled to them and have sacrificed so much for us is grotesque: the moral equivalent of kicking dogs and stealing food from children.

31 May 2014

Scientists explain how green tea may work to reduce risk of cancer

Green tea and its extracts have been widely touted as potential treatments for cancer, as well as several other diseases.

31 May 2014

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

Inovio Pharmaceuticals, Inc. today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

30 May 2014

TSRI scientists receive more than $13M to design effective HIV vaccine

A team led by scientists at The Scripps Research Institute (TSRI) has received a grant of more than $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to study antibodies to the human immunodeficiency virus (HIV)—which will play an essential role in the creation of any effective vaccine against HIV.

30 May 2014

Perelman School wins $10M renewal to study oldest part of human immune system

The National Institute of Allergy and Infectious Diseases has awarded the Perelman School of Medicine at the University of Pennsylvania a five-year, $10 million renewal of a program project to study the oldest part of the human immune system called the complement system, or simply "complement."

30 May 2014

Review on effects of pre-referral rectal artesunate for people with severe malaria

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, conducted an independent review of the effects of pre-referral rectal artesunate for people with severe malaria, published in the Cochrane Library today.

30 May 2014

New approach could lead to more effective HIV vaccine

Using a genetically modified form of the HIV virus, a team of University of Nebraska-Lincoln scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine.

30 May 2014

Infectious Diseases News and Research

New TB blood test could eliminate unnecessary treatment

Device used in physics and chemistry reveals dynamics of pervasive pathogen

Canadian invasive pneumococcal disease outbreak characterised

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

New single-dose antibiotic is as effective as twice-daily infusion given for up to 10 days

NeuroVive extends collaboration with Hospices Civils de Lyon

EC approves extension of INVEGA antipsychotic drug to include adolescents aged 15 years and older

Researchers figure out way to disable a part of SARS virus

Polyarticular juvenile idiopathic arthritis (PJIA): an interview with Dr. Kramer, VP, Immunology and Infectious Diseases Medical Unit, Genentech

Salk Institute receives $25 million for cutting-edge biological research

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

UTHealth’s professor receives highly competitive Fulbright-Nehru Scholarship Award

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Viewpoints: VA's problems begin with Congress; costly hepatitis drug may be a good buy

Scientists explain how green tea may work to reduce risk of cancer

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

TSRI scientists receive more than $13M to design effective HIV vaccine

Perelman School wins $10M renewal to study oldest part of human immune system

Review on effects of pre-referral rectal artesunate for people with severe malaria

New approach could lead to more effective HIV vaccine

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News